Glucagonoma Withdrawn Phase 2 Trials for Dovitinib (DB05928)

Back to Glucagonoma

Also known as: Glucagonomas

IndicationStatusPhase
DBCOND0000819 (Glucagonoma)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02108782Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine TumorsTreatment